211 related articles for article (PubMed ID: 28380457)
1. The integrative metabolomic-transcriptomic landscape of glioblastome multiforme.
Heiland DH; Wörner J; Gerrit Haaker J; Delev D; Pompe N; Mercas B; Franco P; Gäbelein A; Heynckes S; Pfeifer D; Weber S; Mader I; Schnell O
Oncotarget; 2017 Jul; 8(30):49178-49190. PubMed ID: 28380457
[TBL] [Abstract][Full Text] [Related]
2. Microenvironment-Derived Regulation of HIF Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme.
Heiland DH; Gaebelein A; Börries M; Wörner J; Pompe N; Franco P; Heynckes S; Bartholomae M; hAilín DÓ; Carro MS; Prinz M; Weber S; Mader I; Delev D; Schnell O
Mol Cancer Res; 2018 Apr; 16(4):655-668. PubMed ID: 29330292
[TBL] [Abstract][Full Text] [Related]
3. Integrative Diffusion-Weighted Imaging and Radiogenomic Network Analysis of Glioblastoma multiforme.
Heiland DH; Simon-Gabriel CP; Demerath T; Haaker G; Pfeifer D; Kellner E; Kiselev VG; Staszewski O; Urbach H; Weyerbrock A; Mader I
Sci Rep; 2017 Mar; 7():43523. PubMed ID: 28266556
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant network-based signatures cluster glioblastoma into distinct redox-resistant phenotypes.
Yang Y; More S; De Smet F; De Vleeschouwer S; Agostinis P
Front Immunol; 2024; 15():1342977. PubMed ID: 38698847
[TBL] [Abstract][Full Text] [Related]
5. Nicotiana attenuata Data Hub (NaDH): an integrative platform for exploring genomic, transcriptomic and metabolomic data in wild tobacco.
Brockmöller T; Ling Z; Li D; Gaquerel E; Baldwin IT; Xu S
BMC Genomics; 2017 Jan; 18(1):79. PubMed ID: 28086860
[TBL] [Abstract][Full Text] [Related]
6. Identification of Systems Level Molecular Signatures from Glioblastoma Multiforme Derived Extracellular Vesicles.
Roy N; Gaikwad M; Bhattacharrya DK; Barah P
J Mol Neurosci; 2021 Jun; 71(6):1156-1167. PubMed ID: 33231813
[TBL] [Abstract][Full Text] [Related]
7. Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity.
Oizel K; Chauvin C; Oliver L; Gratas C; Geraldo F; Jarry U; Scotet E; Rabe M; Alves-Guerra MC; Teusan R; Gautier F; Loussouarn D; Compan V; Martinou JC; Vallette FM; Pecqueur C
Clin Cancer Res; 2017 Oct; 23(20):6292-6304. PubMed ID: 28720668
[No Abstract] [Full Text] [Related]
8. Metabolic and transcriptomic profiles of glioblastoma invasion revealed by comparisons between patients and corresponding orthotopic xenografts in mice.
Cudalbu C; Bady P; Lai M; Xin L; Gusyatiner O; Hamou MF; Lepore M; Brouland JP; Daniel RT; Hottinger AF; Hegi ME
Acta Neuropathol Commun; 2021 Aug; 9(1):133. PubMed ID: 34348785
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of PD-L1 expression in glioblastoma multiforme.
Heiland DH; Haaker G; Delev D; Mercas B; Masalha W; Heynckes S; Gäbelein A; Pfeifer D; Carro MS; Weyerbrock A; Prinz M; Schnell O
Oncotarget; 2017 Jun; 8(26):42214-42225. PubMed ID: 28178682
[TBL] [Abstract][Full Text] [Related]
10. Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures.
Yerukala Sathipati S; Huang HL; Ho SY
BMC Genomics; 2016 Dec; 17(Suppl 13):1022. PubMed ID: 28155650
[TBL] [Abstract][Full Text] [Related]
11. Molecular differences between cerebral blood volume and vessel size in glioblastoma multiforme.
Heiland DH; Demerath T; Kellner E; Kiselev VG; Pfeifer D; Schnell O; Staszewski O; Urbach H; Weyerbrock A; Mader I
Oncotarget; 2017 Feb; 8(7):11083-11093. PubMed ID: 27613830
[TBL] [Abstract][Full Text] [Related]
12. An integrative analysis of tissue-specific transcriptomic and metabolomic responses to short-term dietary methionine restriction in mice.
Ghosh S; Forney LA; Wanders D; Stone KP; Gettys TW
PLoS One; 2017; 12(5):e0177513. PubMed ID: 28520765
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomic and Proteomic Data Integration and Two-Dimensional Molecular Maps with Regulatory and Functional Linkages: Application to Cell Proliferation and Invasion Networks in Glioblastoma.
Gupta MK; Jayaram S; Reddy DN; Polisetty RV; Sirdeshmukh R
J Proteome Res; 2015 Dec; 14(12):5017-27. PubMed ID: 26464075
[TBL] [Abstract][Full Text] [Related]
14. Using evolutional properties of gene networks in understanding survival prognosis of glioblastoma.
Upton A; Arvanitis TN
IEEE J Biomed Health Inform; 2014 May; 18(3):810-6. PubMed ID: 24058043
[TBL] [Abstract][Full Text] [Related]
15. Integration of transcriptomics, proteomics, metabolomics and systems pharmacology data to reveal the therapeutic mechanism underlying Chinese herbal Bufei Yishen formula for the treatment of chronic obstructive pulmonary disease.
Zhao P; Li J; Yang L; Li Y; Tian Y; Li S
Mol Med Rep; 2018 Apr; 17(4):5247-5257. PubMed ID: 29393428
[TBL] [Abstract][Full Text] [Related]
16. Metabolic remodeling contributes towards an immune-suppressive phenotype in glioblastoma.
Kesarwani P; Prabhu A; Kant S; Chinnaiyan P
Cancer Immunol Immunother; 2019 Jul; 68(7):1107-1120. PubMed ID: 31119318
[TBL] [Abstract][Full Text] [Related]
17. Analyzing Differential Regulatory Networks Modulated by Continuous-State Genomic Features in Glioblastoma Multiforme.
Chiu YC; Hsiao TH; Wang LJ; Chen Y; Chuang EY
IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(6):1754-1764. PubMed ID: 28114032
[TBL] [Abstract][Full Text] [Related]
18. PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA.
Nawaz Z; Patil V; Paul Y; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
Mol Cancer; 2016 Nov; 15(1):74. PubMed ID: 27871300
[TBL] [Abstract][Full Text] [Related]
19. Integration of Metabolomics and Transcriptomics to Identify Gene-Metabolite Relationships Specific to Phenotype.
Patt A; Siddiqui J; Zhang B; Mathé E
Methods Mol Biol; 2019; 1928():441-468. PubMed ID: 30725469
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
